Atomwise Company
Atomwise uses artificial intelligence for drug discovery. We design new molecules for the hardest targets. Our discoveries help our partners deliver better medicines faster.
Investors
Connections from
Founded Date:
2012-01-01
Total Funding:
176645000.0
Investor Type:
For Profit
Employee Number:
94
Funding Status:
Early Stage Venture
Technology:
['BioTech & HealthTech']
Last Funding Type:
Grant
Investors Number:
22.0
Last Funding Date:
2020-10-06
Industry:
Application Software
Headquarters:
United
Estimated Revenue:
2.3